Enzo Biochem Inc (NYSE:ENZ)
$ 1.13 -0.04 (-3.42%) Market Cap: 57.88 Mil Enterprise Value: 4.83 Mil PE Ratio: 1.69 PB Ratio: 0.81 GF Score: 38/100

Q3 2022 Enzo Biochem Inc Earnings Call Transcript

Jun 10, 2022 / 12:30PM GMT
Release Date Price: $2.39 (+6.70%)
Operator

Greetings, and welcome to the Enzo Biochem Third Quarter 2022 Financial Results and Business Update.

(Operator Instructions) As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Chris Calabrese, LifeSci Advisors, Investor Relations for Enzo Biochem. Thank you. You may begin.

Chris Calabrese

Thank you, Melissa, and good morning, everyone. Joining us today from the company are Hamid Erfanian, Chief Executive Officer; and David Bench, Chief Financial Officer.

Enzo issued a press release detailing our financial results for the third quarter of the fiscal year this morning and is now available on the Investor section of the Enzo website.

Before we begin, I would like to read the company's safe harbor statement. Except for historical information, the matters discussed in this news release may be considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities Exchange Act of 1934 as amended.

Such

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot